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Abstract
Small-animal imaging has become an important technique for the development of new
radiotracers, drugs and therapies. Many laboratories have now a combination of different
small-animal imaging systems, which are being used by biologists, pharmacists, medical
doctors and physicists. The aim of this paper is to give an overview of the important
factors in the design of a small animal, nuclear medicine and imaging experiment.
Different experts summarize one specific aspect important for a good design of a
small-animal experiment.
Keywords: Small-animal imaging, Animal models, Animal handling, System performance,
Quality control
Background
The European Association of Nuclear Medicine (EANM) symposium entitled Preclinical
Imaging: Systems, Acceptance Testing and Implementation and Practical Issues was set
up to bring experts from different backgrounds (animal models, handling, quality control
and imaging systems) together and summarizes the most important aspects affecting the
quality in small-animal imaging experiments with a focus on molecular imaging with
PET, SPECT and CT [1, 2]. In this white paper, we summarize in a concise manner the
most important aspects of animal imaging for a general scientific public. The final goal of
the paper is to communicate for these to researchers a methodology for planning animal
experiments and working on a frequent basis in a small-animal imaging facility.
Justification and focus of paper
The final image quality obtained in a molecular animal imaging experiment can be influ-
enced by different factors (Fig. 1): first of all, the isotope, tracer production and labelling
are key components. We did not specifically include this here, as it is very similar to
human studies. The other main factors are the animal models used, how the animal is
treated in between imaging sessions, how it is prepared (and mostly anesthetised before
the experiment) right before the imaging study and how it is treated during imaging
(heating, monitoring, triggering…). Also, the performance, acquisition and reconstruction
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settings and quality control of the imaging system have an important effect on the final
image. The following sections will describe each of these four aspects, and finally, a con-
cluding paragraph will give some guidelines to the reader. The available animal models
and the handling of the animals are described before describing the system performance
and quality control.
Case presentation
Animal models (J. Bankstahl, Hannover)
Animal models are essential for systemic and functional evaluation of (patho-) physio-
logical processes [3]. Over 75 % of animals used for preclinical research are rodents,
which is reflected by the technical specifications of preclinical imaging devices [1, 4, 5].
Today, the spatial resolution of these devices is about 1–1.5 mm. Larger animals, about
the size of a cat or bigger, will usually be scanned on clinical imaging systems, which
requires special consideration of scanner availability, hygiene and experimental setup.
In the early days of radiotracer imaging, due to limited availability of dedicated preclinical
imaging systems, animal models were mainly used in ex vivo bio-distribution or metabol-
ism studies during the early development of new tracers (Fig. 2). As small-animal cameras
have become commonly available, preclinical imaging has become a customary step before
performing first-in-man studies. Although animal experiments have distinctly contributed
to major advances in life sciences, there are acknowledged limitations with regard
to translatability and species differences. Moreover, despite many attempts to improve
quality of animal experiments and its reporting, such as the STAIR or the Animal Re-
search: Reporting of In Vivo Experiments (ARRIVE) initiatives [6, 7], it remains advisable
to use new tracers in man as early as possible and to utilize animal models in parallel in
order to improve protocols and acquire additional knowledge.
As the variety of animal models has vastly increased over the last decades, it is impos-
sible to handle them all single-handed; as such, the imaging specialist will often interact
closely with experts in diverse fields of research. The standard approach for evaluation of
new imaging agents is to intravenously administer the radiotracer in healthy young adult
rodents. One must keep in mind that commercially available rat and mouse strains are
inbred to some extent, even if they are described as outbred, and that genetic drift occurs
over time even within inbred strains [8, 9]. Consequently, proper control animals are
Fig. 1 Different steps in animal studies: the preparation of the imaging probe, the selection of the animal
model, animal handling and the administration of the imaging probe and imaging and quality control
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crucial for all experiments, and historic controls comprise large risks for misinterpretation
of data. Nevertheless, for baseline evaluation of tracer kinetics or evaluation of interactions
with unlabelled compounds, naive animals are the models of choice.
In contrast to the situation in patients, and due to the rarity or absence of many
spontaneous changes in rodents, most animal models used in preclinical research are
induced (Fig. 3). As a general rule, a spontaneous change should be present in at least
20 % of the animals to make preclinical studies feasible. Surprisingly, few preclinical
studies deal with the two most obvious spontaneous parameters, i.e. age and gender,
whereas both parameters are usually investigated in clinical studies. Other spontaneous
changes commonly seen in aged rodents include tumours. Despite some exceptions,
Fig. 3 Simplified overview about different types of animal models
Fig. 2 Use of animal models in preclinical radiotracer imaging. The dotted arrow indicated the workflow for
new tracers before the availability of preclinical scanners
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such as incidences of >37 % for spontaneous pituitary tumours in male Wistar
Hannover rats over one-year old [10], the unpredictable age of disease onset and
frequency renders such “natural” models impractical for preclinical research.
Induced disease models include a huge variety of approaches, often employed in
combination. Surgical approaches can include vessel occlusion for induction of heart
ischemia or stroke, organ removal or transplantation and many more. Chemical disease
induction uses various pharmacologically active and/or toxic compounds to selectively
kill specific cell types, for instance, beta cells of the pancreas, or to induce a status epi-
lepticus. Cell implantation for disease induction is often used in preclinical oncology.
Cell transplantation, especially using different kinds of stem cells, as a treatment option
is one of the most exciting areas of current preclinical research [11]. Finally, the wider
availability of diverse genetically modified animals gives the opportunity to investigate
the biology of gene modification or knockout and gives exciting mechanistic insight
into many diseases, which do not spontaneously occur in rodents, such as Alzheimer’s
disease [12]. In addition, a gene of an acceptor can be replaced by the gene of a donor,
as in the case of transgenic mice, which carry healthy or malfunctioning human genes.
All types of genetically modified animals can of course be combined with other induced
or spontaneous disease models, as well as multiple treatment approaches, leading to
innumerable options for improvement of scientific knowledge.
Animal handling between, before and during imaging experiments (S. Krämer, Zurich)
Legislation, guidelines and experiment planning
Since the year 1959, when Russell and Burch published “The Principles of Humane
Experimental Technique” (http://altweb.jhsph.edu/pubs/books/humane_exp/het-toc), eth-
ical aspects and animal welfare have gained much attention in animal research. Russell
and Burch introduced the concept of the 3R’s, Replacement, Reduction and Refinement
and international, national and institutional legislation, and guidelines nowadays follow
these principles, respecting ‘the intrinsic value of an animal (the value in its own right)’.
Consequently, research with animals requires justification and a dedicated education and
certification. Experiments have to be planned and conducted in accordance with the
European (http://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32010L0063) or
other supranational, national and institutional legislations. Within Europe, the Federation
of European Laboratory Animal Science Associations (FELASA) represents its members’
common interests in the furtherance of all aspects of laboratory animal science (http://
www.felasa.eu) and when publishing animal experiments, many Journals ask for the
statement that experiments were planned, conducted, interpreted and reported
according to the ARRIVE guidelines on Animal Research: Reporting In Vivo Experi-
ments (http://www.elsevier.com/__data/promis_misc/622936arrive_guidelines.pdf ).
The careful planning of an experiment is the key to keep the number of required
animals at a minimum but still reaches a predefined chance to find the true effect of a
treatment (see “Number of animals required for an imaging experiment” section). The
webpage of the UK National Centre for Replacement Refinement and Reduction of
Animals in Research (NC3Rs; http://www.nc3rs.org.uk) provides valuable protocols,
not only for power analysis to find the optimal group size for an experiment but
also for many other experimental details. Consulting the above and national and
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institutional webpages and guidelines before planning an experiment with animals
is inevitable. In the following, some of the details with relevance for small-animal
imaging are discussed.
Animal housing
The transport of the laboratory animals to the research facility, the new environment and
personnel all cause stress to the animals, which potentially influences the results of an
experiment. For this and for reasons of animal welfare, animals should in general be trans-
ported to the facility about 1 week before the experiment. Regarding their housing, an
enriched environment not only is less stressful to the animals than an unenriched cage but
may also give more reproducible results [13]. Enrichment refers mainly to refugees and
bedding and nesting material. Bored animals in an unenriched cage often develop stereo-
typic behaviour. This is repetitive activities at short intervals, and it would come as
a surprise if neurotransmitter signalling—the target of most neuroimaging pro-
jects—would not be affected in one or the other way in bored animals and animals
with stereotypic behaviour. In fact, housing in isolation affects the cognitive func-
tion of an animal and is even used as a model of depression in research [14, 15].
According to the animal welfare legislation, the isolated housing of an animal must
be avoided if it is not required for a defined reason. However, mixing animals from
different cages or any stressful event can result in harmful hierarchy fights, in par-
ticular, between males, again, potentially influencing an imaging experiment. The
animals should thus be housed in stable groups in enriched cages, taking into
account the minimal space requirements for their well-being. The required minimal
available space per animal and maximal number of animals per cage are defined in
national and European Union (EU) regulations and guidelines. Appendix A (Guidelines
for accommodation and care of animals—Article 5 of the convention) to the European
Convention for the Protection of Vertebrate Animals used for Experimental and Other
Scientific Purposes (ETS No 123) contains tables with information of minimal floor area
and cage height besides many more useful information regarding animal housing and
animal welfare in general. Using larger cages than the recommended minimal size
allows more and diverse enrichment and finally better imitating the natural envir-
onment of the animals.
As the housing of male and female animals of the same species or animals from
different species in the same room causes or may cause distress to the animals, gender
and species need to be separated accordingly [16]. The most common solution is the
use of individually ventilated cages that reduce the exchange of odours and dust
between cages and racks of cages. Planning a facility, it should also be kept in mind
that housing and experimenting need to be separated in two different rooms with a
barrier for noise and odours.
Small animals are sensitive to temperature and humidity. Both need to be strictly
controlled in an animal facility. Optimal parameters differ depending on the species
and strain. The ideal temperature is higher for nude mice than mice with fur. It may be
wise to consult the breeder for detailed information on the conditions that the animals
are habituated to. In general, rats and mice facilities should have a constant
temperature between 20 and 24 °C and a humidity between 35 and 55 % (Appendix A
to ETS No 123). Nesting material allows the animals keeping their preferred
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microclimate. Besides temperature and humidity, ventilation needs strict control to
allow sufficient exchange of breathing air, odours and noxious gases and control of
local temperature levels.
Mice and rats are active during the dark phase. For practical reasons, their facilities are
usually controlled by a light-dark cycle synchronized with daylight, with a 12/12-h interval,
with the consequence that the animals are in their inactive phase during experimental time.
This should be taken into account in experiments with circadian variations. The light
source needs special attention. Even during the light phase, the light needs to be dimmed
to prevent degeneration of the sensitive retina of rodents, in particular of albino rodents.
Animal handling and education
Animal handling requires a dedicated education, provided by certified national or inter-
national organizations. In recent years, FELASA defined categories of educational level
and the detailed theoretical and practical contents as well as the respective numbers of
hours to be spent on education. This included topics related to ethics, legislation,
animal housing, breeding and handling, animal behaviour, health monitoring, evalu-
ation of categories of severity of an experiment, recognition of and methods to reduce
pain, distress and other unhealthy conditions, reporting and common experimental
techniques. Within the EU, education is now regulated by the directive 2010/63/EU on
the protection of animals used for scientific purposes and by the national legislations
based on the EU directive. The EU is setting up a platform on education and training
in laboratory animal science (Education and Training Platform for Laboratory Animal
Science—ETPLAS) with the goals to “help facilitate mutual recognition of laboratory
animal science education and training programs, free movement of personnel within
the EU and provide stakeholders with information on high quality training programs”
(http://www.etplas.eu).
Animal handling can have a significant influence on an experiment as it may cause
distress to the animals if it is not properly done. Stress factors include inadequate environ-
mental conditions, inapt contacts between researcher and animals, unfamiliar noise,
odours, vibrations and hectic gestures besides the transfer of pathogens between facilities,
rooms or cages and the unawareness of signs of animal discomfort, distress or pain. It is
thus for the benefit of the animals and of the experiment that the requirement for the
respective education is regulated by EU and national law.
Hygiene and health monitoring
Imaging platforms can easily become hubs for (potentially) pathogenic microorganisms.
Several precautions help to minimize this risk. Animal facilities, and in particular, those
transferring animals to others, should monitor the facility according to a list of speci-
fied pathogens and keep book in health certificates [17]. Several organizations offer
analytical services to test sentinel animals or excreta for contamination with defined
microorganisms. Before exchanging animals between facilities, the health certificates
need to be exchanged, and only if the receiving facility’s negative list of pathogens is
tested negative over a defined time period in the source facility/facilities, the animals
can be transferred. Alternatively, and if infrastructure and risk assessment allow, rooms
with differing hygiene levels or quarantine rooms can be defined and common instru-
ments cleaned and decontaminated accordingly. However, it should be kept in mind
that any infection or its treatment could affect the imaging results.
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In addition to the hygiene status, animals need to be monitored for their general
well-being. This is usually done according to a pre-defined criteria catalogue and if
required individual score sheets, both requiring approval by the respective authorities
[18]. Depending on the animal model, score sheets consider, e.g. body weight, appearance
of coat, posture, breathing, self-care and social behaviour and appearance of excreta
besides disease-related aspects. These score sheets unambiguously define at which state
an experiment needs to be terminated and the animal killed. Consulting these score sheets
may be of valuable help for the interpretation of unexpected imaging results.
Nutrition
Due to their small size, mice have a much higher body surface to body volume ratio than
humans resulting in a higher relative water loss through skin. Drinking water should,
therefore, not be withdrawn and during longer experiments, lost water needs to be
replaced. For PET imaging with the glucose analogue [18 F]FDG, food is often withdrawn
for a few hours to reduce the plasma level of glucose, which competes with [18 F]FDG for
cell uptake. It depends on the region of interest, e.g. tumour, brain, myocardium, skeletal
muscle, to which extent fasting or plasma glucose levels will have an influence on the
results [19, 20]. As mice feed frequently and may reach a state of torpor after 7 h of food
withdrawal, the fasting period should be kept at a minimum duration [21]. Over-
night fasting, what is often seen in publications, is definitely too long if it lasts, e.g. from
5 pm to 10 am, until the experiment is completed. In addition, mice feed most during the
dark period, which in most laboratories is overnight.
Anaesthesia
Small-animal SPECT or PET scans typically last between 15 and 90 min. In most cases,
animals are immobilized during this time by light anaesthesia. Volatile anaesthetics such as
isoflurane are preferred as the duration and depth of anaesthesia can easily be controlled,
and response to dosage adjustments is immediate. Isoflurane is metabolized to a reactive
metabolite that can cause hepatotoxicity, an issue for researchers who are exposed to the
anaesthetic on a daily bases. Sevoflurane is a good alternative in this respect, though more
expensive. These volatile anaesthetics require a dedicated anaesthesia system including
vaporizer and flow metre. They are administered via a carrier gas that is inhaled by the
animal. For long anaesthesia periods, the carrier gas may be humidified with water to avoid
dehydration of the respiratory airways. Excess and exhaled anaesthetic is aspirated and
removed by ventilation or trapped in activated charcoal canisters to reduce immediate and
long-term health problems of the experimenters due to isoflurane.
The carrier gas is in most cases a 1:1 mix of oxygen and air that allows regulating the
delivery of oxygen to the animal and thus the oxygen pressure in the blood. Hypoxia can
be reduced to a minimum or induced with the respective consequences on the experi-
mental outcome. This is of particular interest in hypoxia imaging [22]. Both isoflurane
and sevoflurane anaesthesia cause respiratory depression with hypercapnia, acidosis and a
decrease in respiration rate within 10 to 50 min after anaesthesia induction [23]. Amongst
the frequently used injected anaesthetics are ketamine, often in combination with the
muscle relaxant xylazine, furthermore, propofol, chloral hydrate and pentobarbital. Table 1
shows some of their properties [24–26]. The mode of action is not fully understood for
most anaesthetics. In particular, those with small, simple structures and high dose interact
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with several neuroreceptors and other proteins involved in neurotransmitter signalling
and in addition affect membrane fluidity.
Most anaesthetics not only interfere with neurotransmission in the brain but also affect
cardiovascular and respiratory parameters and other physiological functions as discussed
above for isoflurane and sevoflurane. Cardiac output, blood pressure and blood flow may
change, and due to the high body surface to volume ratio, body temperature may rapidly
drop during anaesthesia, requiring heating of the animals. The respiratory rate is reduced
and can be used as an indicator of the depth of anaesthesia. Several anaesthetics affect
glucose and insulin levels. Anaesthesia-related neurological and peripheral effects can
significantly affect the imaging results, and as the effects are often multifactorial, their
extent is generally not predictable.
Alstrup and Smith recently reviewed the literature for effects of anaesthesia on PET im-
aging [27]. Cerebral blood flow is enhanced under isoflurane and ketamine but reduced
under propofol anaesthesia. Brain uptake of tracers with high extraction at the blood-brain
barrier will be accordingly affected with higher uptake (K1) at increased and lower uptake
(K1) at reduced cerebral blood flow. As cerebral glucose consumption is typically reduced
under anaesthesia, [18 F]FDG uptake in brain is reduced with most anaesthesia protocols,
including isoflurane, ketamine, propofol, chloral hydrate and pentobarbital anaesthesia.
Several studies report on the effects of anaesthesia on neurotransmitter transporter and re-
ceptor imaging. To give two examples, under isoflurane or ketamine/xylazine anaesthesia,
Table 1 Frequently used anaesthetics in small-animal imaging
Anaesthetic Pharmacology,
interaction with
Application
route
Typical duration
of anaesthesia
Note
Isoflurane, sevoflurane Various neuroreceptors and
other proteins involved in
neurotransmission
Inhalation
with air/
oxygen
Controlled by
inhalation
Isoflurane:
Hepatotoxicity
(staff!)
Ketamine (ketamine/xylazine) Various neuroreceptors and
other proteins involved in
neurotransmission
i.p. (rats, mice);
i.m. (rats)
20 to 30 min
(sleep 1 to 2 h)
Xylazine
against muscle
rigidity
Propofol GABAA and various other
proteins involved in
neurotransmission
i.v. bolus +
infusion
Controlled by
infusion
Chloral hydrate, alpha
chloralose
Various neuroreceptors and
other proteins involved in
neurotransmission
i.p. 1 to 2 h (rats) Alpha
chloralose is
the acetal
between
chloral hydrate
and glucose
Pentobarbital GABAA receptor agonist i.p. 15 to 60 min
(mice), 70 to
100 min (rats),
(sleep 1 to 3 h)
Fentanyl/fluanisone–midazolam
(hypnorm–dormicum)
Opioid receptor (fentanyl),
dopamine receptors
(fluanisone), GABAA
receptor (midazolam)
i.p. 20 to 70 min
(mice), 10 to
110 min (rats),
(sleep 1 to 3 h)
Urethane Various neuroreceptors and
other proteins involved in
neurotransmission
i.p. >24 h Modest
influence on
cardiovascular
and respiratory
systems
For references, see text
i.p. intraperitoneal, i.v. intravenous
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accumulation of the dopamine transporter (DAT)-targeting 125I-labelled imaging tracer
PE2I was reduced in rat striatum [28] and quantitative PET with the dopamine 1 receptor
(D1) targeting [11C]SCH23390 significantly differed between conscious rats and rats
anaesthetized with chloral hydrate, ketamine or pentobarbital [29].
As effects of anaesthesia on SPECT and PET results cannot be avoided, it is crucial to
standardize protocols as carefully as possible to allow quantitative comparison of the
imaging results.
Application of tracers and drugs
The small blood volume of a mouse, which is about 58.5 mL per kg body weight
(http://www.nc3rs.org.uk) i.e. about 1.5 mL for a 25 g mouse, limits the volume of
tracer or drug solution that can be applied. As the total tracer dose needs to be contained
in a small volume, relatively high tracer concentrations are required in the formulations for
small-animal imaging. Table 2 shows recommended (maximal) volumes applied by various
routes for mice and rats according to the NC3Rs guidelines. More detailed information on
recommended volumes and sites for substance administration and blood sampling is
provided by e.g. K.H. Diehl et al. [30].
Intravenous bolus is the most frequently used administration protocol in small-animal
imaging. Larger volumes than maximally tolerated by bolus injection may be applied by
intravenous infusion. For kinetic modelling, intravenous infusion over a few minutes may
even improve modelling accuracy, as the initial part of the blood curve can be better
defined with this protocol. However, the infusion phase should not be too long, as other-
wise information on K1 may get lost. Infusion over about 5 min was optimal for kinetic
modelling with [18F]FDG in mouse brain.
Besides the volume the pH, osmolality, viscosity and addition of co-solvents are critical
factors for substance administration [31, 32]. The recommended pH range for intravenous
administration is 2–9. A slow rate of injection in the case of non-physiological conditions
reduces the occurrence of adverse effects such as cardiovascular failure. Intraperitoneal
administration is more sensitive to non-physiological conditions than intravenous admin-
istration where the injected volume is immediately diluted and buffered by the blood pool.
For intraperitoneal administration, the pH should be physiological and vehicles limited to
saline or water. Tolerated co-solvents for intraperitoneal administration include propylene
glycol or polyethylene glycol 400 (PEG400).
Blood sampling
Blood sampling during SPECT and PET scans is required for kinetic modelling, to de-
termine blood parameters during the scan, such as the concentration of glucose or the
extent of radiotracer metabolism. It is again the small volume of blood that renders
blood sampling in small animals particularly challenging. Table 3 shows the maximal
Table 2 Maximal administration volumes for rats and mice
Route Rat Mouse
Intravenous bolus 5 mL/kg (1 mL/200 g rat) 10 mL/kg (0.2 mL/20 g mouse)
Intraperitoneal 10 mL/kg (2 mL/200 g rat) 20 mL/kg (0.4 mL/20 g mouse)
Oral 20 mL/kg (4 mL/200 g rat) 20 mL/kg (0.4 mL/20 g mouse)
Subcutaneous 10 mL/kg (2 mL/200 g rat) 20 mL/kg (0.4 mL/20 g mouse)
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volumes of blood that can be withdrawn once or repeatedly. Arterial blood samples
may be withdrawn from a femoral or tail artery. For venous blood sampling, several
veins are easily accessible. These are, e.g. the tail vein, sublingual vein or the subman-
dibular vein. The tail vein may be cannulated for repeated blood sampling while the
sublingual and submandibular veins are better suited for puncture with a sharp needle
or lancet [30, 33, 34]. For the recording of an input function for kinetic modelling,
protocols with arterio-venous shunts may be preferred as this allows the quantification
of radioactivity in blood at a high temporal resolution without blood loss as the blood
is guided back into the animal [35].
Finally, at the end of each experiment or during a terminal experiment, the animal
needs to be euthanized. Methods of “humane killing” are specified by the legislation and
the respective guidelines. Common criteria for humane killing are minimal pain, distress
and discomfort for the animal and rapid and confirmed death. Bleeding following any
other euthanasia method is an unambiguous way to guarantee death of the animal. A
common and hardly debated method is decapitation of the anaesthetized animal with a
rodent guillotine.
Number of animals required for an imaging experiment (C. Vanhove, Gent)
With the growing knowledge of new targets related to specific disease and the devel-
opment of novel molecularly targeted therapies, the number of animals used for non-
invasive imaging experiments using SPECT and PET has increased. It is important to
note, however, that it is required to take careful attention to the number of animals
needed to produce truly useful data from any imaging experiment [36]. The rationale be-
hind choosing a correct sample size is to weigh the benefits; one can gain in information
against the cost of increasing the sample size. The number of animals to be acquired to
reach statistically significant differences between groups can be computed using a priori
statistical power analysis. Software such as InStat (http://www.graphpad.com), G*Power
(http://www.gpower.hhu.de) and Interactive Statistical Calculation Pages (http://
statpages.org) can be used to simulate the significance of the results. Based on the
two-tailed Student’s t test with the assumptions of equal standard deviation in the
control and treatment/disease groups, and unpaired data analysis if different animals are
used for each group, the goal is to calculate the number of animals to achieve a significant
difference (P < 0.05) between the control and treatment/disease groups [37, 38]. The
ability of an in vivo imaging experiment to measure statistically significant differences
Table 3 Maximal volumes of blood sampling
Species Body weight Blood volume per
kilogramme body weight
Blood volume at
typical body weight
Maximal volume for
blood sampling
Human 70 kg 67 mL/kg 4.7 L
Rat 400 g 64 mL/kg 26 mL 2.6 mL (10 %) at once
0.26 mL (1 %)/24 h repeatedly
6.5 mL (25 %) within 28 days
Mouse 25 g 59 mL/kg 1.5 mL 0.15 mL (10 %) at once
0.015 mL (1 %)/24 h repeatedly
0.37 mL (25 %) within 28 days
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between a control group and either diseased or treatment groups is further
dependent on the intra-animal variability of the acquired data. This variability can
be estimated using a test-retest experiment by calculating the ratio between stand-
ard deviation and the mean of the two measurements [39]. Table 4 summarizes the
number of animals required per group to reach statistical significance in relation
to the expected difference between the control and treatment/disease groups and
the intra-animal variability of the SPECT/PET data. Given this summary, it can be
observed that it is important to decrease the intra-animal variability to a minimum,
which can be achieved by standardizing imaging protocols.
System performance and image reconstruction (C. Vanhove, Gent)
Although SPECT and PET imaging has been used as an important clinical tool for
several decades, it can also find a use for preclinical research by imaging small-
animal models of human disease [1, 40–44]. Small-animal SPECT and PET
systems are often modified versions of their clinical equivalent, where rats and
mice form the majority of the experimental animal population. A mouse is
approximately 3000 times smaller by volume than a human (25 g versus 75 kg),
which means that when clinical systems have volumetric spatial resolutions in the
order of 1 cm3, preclinical systems require a volumetric spatial resolution of
0.3 mm3, or sub-millimetre linear spatial resolution, to visualize sub-compartments
of mouse organs.
To obtain this required spatial resolution, most commercial available preclinical
SPECT system is based on pinhole collimation. In clinical practice, the pinhole collima-
tor has been mainly used for imaging small volumes, such as the human thyroid.
Similar to radionuclide thyroid imaging, the magnification of the projection images due to
the pinhole geometry can dramatically reduce information loss as a result of the intrinsic
spatial resolution of the gamma detector when an animal is brought in close proximity to
Table 4 Number of animals required per group to reach statistical significance in relation to the
expected difference between control and treatment/disease groups and the variability of the measured
data. Data were computed using G*Power by a two-tailed unpaired Student’s t test assuming equality
of variance in both groups and normal distributions. Furthermore, a false positive rate (type I error) of
5 % was selected, together with a false negative rate (type II error) of 20 %, corresponding to a power
of 80 %
Expected change between control and
treatment/disease groups in %
Intra-animal variability of the
SPECT/PET data in %
Number of animals
required per group
20 10 6
20 15 10
20 20 17
25 10 4
25 15 7
25 20 12
30 10 4
30 15 6
30 20 9
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the pinhole opening (Fig. 4). The spatial resolution of a pinhole system is approximated
by the following formulae:
Rs ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
de 1þ 1
M
  2
þ Ri
M
 2s
ð1Þ
Here, de is the effective diameter of the pinhole opening taking into account the possible
penetration of the gamma rays through the edges of the pinhole aperture and Ri is the in-
trinsic spatial resolution of the gamma detector. M represents the pinhole magnification
and is defined asM = t/b (see Fig. 4), with t being the distance between the pinhole opening
and the detector surface and b the distance between the object and the pinhole opening.
For most clinical gamma cameras, Ri is typically between 3–4 mm, indicating the magnifi-
cation larger than 4 might result in sub-millimetre intrinsic spatial resolution. The greater
challenge is then to acquire a sufficient number of counts in each individual voxel to
support this high spatial resolution and thus to obtain sufficient signal-to-noise ratios com-
parable to clinical system. The sensitivity of a pinhole system is approximated by:
S ¼ de
2
16b2
 
N ð2Þ
where N representing the number of gamma detectors used. As a result, the sensitivity
of a pinhole SPECT system can be improved by increasing the diameter of the pinhole
opening to allow more gamma photons to pass; however, this will be at the cost of a
poorer spatial resolution. Further minimizing the distance between the animal and the
pinhole will also increase the fraction of detected photons in the field of view, as a
result of the increasing solid angle, but it will restrict the size of the field of view. These
choices between spatial resolution, sensitivity and size of the field of view need to be
carefully examined in view of the species and organs to be imaged. The need for high
Fig. 4 Principles of pinhole collimation with b representing the distance between the object and the pinhole
opening and t representing the distance between the pinhole opening and the gamma detector. de denotes
the effective diameter of the pinhole opening accounting for penetration of gamma rays through the edges of
the pinhole aperture
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spatial resolution, in combination with high sensitivity and a realistic size of the field of
view has driven the development of multi-detector multi-pinhole systems [45, 46].
These systems increase the sensitivity roughly by factor equal to product of the number of
detectors and number of pinholes. The detection efficiency of each individual pinhole in
these multi-pinhole systems is lower than that of single-pinhole system, in which entire
detector area can be used with high magnification. Though, when carefully designed, the
sensitivity can be substantially improved while maintaining the same final spatial reso-
lution and size of the field of view [45]. Another possibility to further increase the sensitiv-
ity is to allow overlap between the multiple pinhole projections on the detector surface,
which is also referred to as multiplexing [46, 47]. However, it is important to note here
that in the overlapping regions, it is impossible to determine through which pinhole a
photon travelled before reaching the detector. As a result of this ambiguity, reconstruc-
tions of multiplexed multiple-pinhole data converge more slowly than those of non-
overlapping projections, resulting in more noisy images. Consequently, the sensitivity
advantage of overlapping projections does not necessarily result in an improved
signal-to-noise ratio and may only compensate for the introduced ambiguity [47].
Today, all commercial small-animal SPECT systems are based on the multi-detector
multi-pinhole geometry using different configurations, including conventional systems
where the detector, together with the collimator, rotates around a stationary animal [4, 48],
systems where the collimator rotates around a stationary animal and in front of a stationary
detector [49] and systems where the animal, collimator and detector are stationary [4, 50].
Preclinical PET systems use similar image formation techniques as human PET
systems and can be seen as scaled down versions of clinical systems. Small-animal PET
systems also use a cylindrical geometry with a typical diameter of ±15 cm as compared
to ±80 cm for clinical PET systems. An advantage of using a smaller detector ring is
that it saves detector cost, which allows PET developers to expand the detector rings in
the axial direction, improving the geometric detection efficiency of the system. The
axial field-of-view of preclinical PET systems is typically ±8 cm, which is more or less
equal to the length of a mouse, allowing to measure the whole-body dynamic bio-
distribution of a labelled compound in a single scan. To obtain the required spatial
resolution for small-animal imaging, scintillation crystals with smaller pixel pitch have
to be used. However, fine pixels are difficult to produce and may result in a very expen-
sive imaging system [51]. On the other hand, to provide adequate sensitivity, scintillator
crystals should be long. This leads to scintillator arrays made of long and narrow crystals
that will increase photon penetration in the scintillator array causing a parallax position-
ing error that worsens spatial resolution. This parallax error can be mitigated through the
use of a few short crystals to replace each single long crystal [52], by modelling the
spatially variant detector response functions in the reconstruction algorithm [53] or by
using monolithic crystals instead of pixelated detectors. To our knowledge, the best spatial
resolution reported for state-of-the-art small-animal PET systems has been about 0.7 mm
full-width-at-half-maximum [54] and the highest reported absolute sensitivity at the
centre of the field of view is approximately 14 %, which is about six times that of the
current state-of-the-art human PET scanners [55].
Next to spatial resolution, two other issues of resolution are also important when
dealing with small-animal imaging systems, namely, energy resolution and timing
resolution.
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The energy resolution is important as better energy resolution improves the discrim-
ination between true unscattered events (i.e. the desirable events for image formation)
and Compton scattered events (i.e. undesirable events that affect quantitation and
reduce contrast) within the animals being imaged. Because Compton scattering is of
decreasing relevance as the photon energy increases, a high-energy resolution is more
of a concern in case of SPECT, where lower photon energies are used, compared to
PET. Furthermore, SPECT has the capability to simultaneously image multiple radionu-
clides with different emission energies, and a good energy resolution is here very import-
ant to minimize cross talk between the different simultaneously acquired radionuclide
measurements. As a result, similar to the clinical, narrower energy windows are used in
preclinical SPECT, with a typical width of 10–20 % around the photopeak, while in
preclinical PET, very large energy windows are used (350–650 keV).
The timing resolution of a gamma detector is correlated with the decay time and light
output of the scintillator. In general, faster decay times corresponded to better timing
resolution. Timing resolution is important for separating events in PET and SPECT
(count-rate performance) but is of less importance in preclinical imaging because of the
lower dose levels applied. However, in preclinical PET, a good timing resolution results in
a good coincidence timing that is still important for limiting the collection of random
events. Generally, a time coincidence window of approximately 10 ns is used in small-
animal PET.
For emission tomography, there are two categories of reconstruction algorithms, namely,
analytical and iterative methods. Although, analytical methods are computationally very
efficient, they are not suited to deal with the complex multi-detector multi-pinhole SPECT
geometry. As a result, iterative reconstruction techniques, such as maximum likelihood
expectation maximization, are routinely used in preclinical imaging. Moreover, similar to
clinical systems, preclinical PET systems often implement three-dimensional data acquisi-
tions in list mode that are iteratively reconstructed using an MLEM-based algorithm [53].
In addition, the more important need for absolute quantification in preclinical imaging, to
better understand the pathophysiology of disease and the impact of treatment, further
increases the necessity of iterative reconstruction algorithms. Two criteria characterize the
reliability of absolute quantification, namely, accuracy and precision [56]. Iterative recon-
struction algorithms can substantially improve both criteria because they include an appro-
priate statistical model to describe the data, resulting in better noise properties and thus
improved precision, and they allow to accurately model image degrading effects such as
attenuation, scatter and partial volume effects, resulting in a more accurate representation
of the tracer distribution when a sufficient number of iterations are used [57]. Similar to
the clinic, partial volume effects can be decreased by modelling the spatially variant de-
tector response [54, 57] and scatter can be estimated by using measurements in additional
energy windows [58] or using the more complex single-scatter simulation technique [59].
Attenuation correction requires a co-registered map of attenuation coefficients at the
relevant photon energy that for the majority of preclinical systems can be provided by CT
[60]. Small-animal CT imaging is usually based on the cone-beam CT geometry [61–63].
In some preclinical SPECT/CT systems, the SPECT and CT components are mounted on
the same rotating gantry (in-plane configuration). Another way to combine the two
modalities is to keep the two imaging systems separate and to translate the animal
between two imaging modalities that are bolted together in a tandem configuration (serial
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configuration), analogous to clinical SPECT/CT and PET/CT systems. Along with provid-
ing an accurate attenuation map, the CT information can be used to provide anatomical
localization. In small-animal imaging, this is very important because novel radiopharma-
ceuticals with high specificity for their target have less non-specific uptake in surrounding
organs, suppressing ‘anatomical landmarks’ in the functional images. Moreover, unfamiliar
animal anatomies that are not corresponding to human anatomy, and the limited field of
view due to the pinhole geometry in SPECT, further necessitate CT imaging.
In summary, the crucial trade-offs in the design of preclinical imaging systems are
between spatial resolution, sensitivity and size of the field of view. Other important
requirements include accurately co-registered CT images and absolute quantification. It
should be emphasized that for accurate quantification, the acquired image data should be
corrected for all image-degrading effects and reconstructed with a sufficient number of
iterations. It is also important to note that the reconstructed voxel size should be at least
smaller than the spatial resolution of the imaging system to minimize partial volume
effects due to pixilation.
Cross-calibration (C. Vanhove, Gent)
In small-animal SPECT and PET imaging experiment, it is a common practice to
perform sample counting. Samples can be blood or tissue samples measured using an
arterial blood counter or gamma counter, respectively. In both cases, it is important to
perform cross-calibrations between SPECT/PET camera, dose calibrator and blood/
gamma counter. Cross-calibration is a direct, relative calibration between the institu-
tion’s own dose calibrator, SPECT/PET camera and blood/gamma counter. In short, the
procedure is as follows: a syringe has to be filled with a radioactive solution with an ac-
tivity (in Bq) that is close to the injected activity applied during the animal experiment.
This syringe should be measured in the institution’s dose calibrator. The solution
should then be introduced into a calibration phantom (mostly a cylindrical phantom)
with an exact known volume (in mL) filled with water, resulting in a solution with
known activity concentration in becquerel/millilitre. Attention should be paid to the
homogenization of the solution. A SPECT/PET scan has to be performed of the calibra-
tion phantom, and the acquired data should be reconstructed applying the same recon-
struction parameters as used during the animal experiment. A volume-of-interest has
to be drawn on the reconstructed images in order to determine the average volumetric
concentration of activity within the phantom as measured by the SPECT/PET scanner.
Samples should then be taken from the calibration phantom, to be measured by the
blood/gamma counter. Conversion factors can then be directly derived with which the
measurements/counts from the different equipment can be synchronized [64].
Acceptance testing and quality control (E.P. Visser, Nijmegen)
General considerations
Quality control (QC) determines the integrity of nuclear medicine equipment in clinical
routine or in (preclinical) research studies. High standards are needed, especially in rela-
tion to image quality, quantitative imaging and size or volume measurements in therapy
and dosimetry. Also, in pharmacokinetic modelling, used in human or animal research,
Vanhove et al. EJNMMI Physics  (2015) 2:31 Page 15 of 25
high standards are needed to guarantee the accuracy of results in terms of pharmacoki-
netic rate constants.
Although research institutes may have service contracts with their equipment suppliers,
several QC procedures should be carried out on a regular basis by the technologists or
physicists working in the institute. It should, however, be mentioned that a QC
programme can never replace the normal attentiveness of the ‘operator’ in observing
equipment problems that are immediately obvious. Instead, a QC programme aims at
detecting those changes that happen so slowly that they are normally not detected in
everyday use.
Selection of tests and criteria to be met
Equipment suppliers generally have many protocols available to assess whether their
equipment meets all specifications. Most of these protocols are complex and time-
consuming and often need special test equipment and phantoms. To guarantee the
normal day-to-day functioning of the equipment, fewer and simpler tests can be used.
A QC programme should provide concrete test results that should be compared with
predefined values, usually the ones obtained during acceptance tests. Action threshold
values should be defined, as well as a protocol for the actions to be taken whenever
certain thresholds are exceeded.
The ‘costs’ and ‘benefits’ of a QC programme have to be balanced. Examples of costs
are the downtime of the equipment, personnel costs, costs of phantoms, radioactive
sources and the radiation burden to the personnel. The level of benefit is related to the
chance that if any degradation has actually occurred, it will be detected by the test and
that the consequences of the degradation (for example, a faulty diagnosis, the need to
repeat the scan…) can be prevented.
Frequency of tests: cost-benefit aspects
In a straightforward approach, fixed test frequencies can be used. However, one risk
that too few tests are performed is leading to a greater chance that the equipment may
not always be at its optimum condition. On the other hand, in case of too many tests,
the equipment is not available for animal research for long periods of time, thus
increasing the effective cost of the equipment. For this reason, adaptive frequencies
should be used, that is, the test frequencies should be adapted to the reliability of the
equipment and the conditions of use.
As a rule of thumb, one should start with a relatively high frequency, which can be
halved if no deviations exceeding the action threshold occur during four consecutive
tests. This will generally lead to the optimal test frequency. In case of a sudden,
unexpected deviation, the frequency should be increased again. However, a certain
minimum frequency should still be used; mostly, this coincides with the frequency
of (preventative) maintenance of the equipment.
Since small-animal imaging equipment is rather diverse, it is not possible to exactly
describe the necessary tests and their recommended frequencies in the present guidelines.
Instead, we refer to the recommendations as given by the equipment manufacturers
However, in case of a small-animal study where quantification is (all-)important, special
attention must be paid to all checks, and if necessary, adjustments, which are directly
related to quantification of activity concentrations in the images. These include the
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calibration factor (as determined using the same settings as in the small-animal
experiment), normalization procedures, detector setup and adjustment of energy peak
positions, etc. In these cases, it is advised to perform these tests before each experiment.
Finally, it is recommended to perform all available tests after each (major) hard or soft-
ware upgrade.
Action levels
Whereas test procedures and equipment specifications are generally described in a
very exact way (e.g. in NEMA procedures), this does not hold for action threshold
levels. In general, it is not possible to define absolute values for action levels from
‘first principles’. Instead, action levels are determined by experience with the cost-
benefit aspect in mind. With the proper choice of action levels, degradations should not
yet have reached a stage where they can be detected in clinical images, but on the
other hand, the equipment is not put out of use for readjustments, calibrations, for
a too longtime period.
NEMA tests
The National Electrical Manufacturers Association (NEMA) has issued four documents
dealing with performance measurements of nuclear medicine equipment. These are
gamma camera’s (NU1), PET scanners (NU2), non-imaging intra-operative gamma
probes (NU3) and small-animal PET scanners (NU4) [5]. It is seen that, unfortunately,
NEMA standards do not (yet) exist for small-animal SPECT scanners. The NEMA
standards have been created by task forces consisting of members from industry and
academia. They are consensus documents, which implies that ‘the information in the
publication was considered technically sound by the consensus of persons engaged in
the development and approval of the document at the time it was developed’. It is how-
ever mentioned in each publication that ‘consensus does not necessarily mean that
there is unanimous agreement amongst every person participating in the development
of the document’.
Basically, the documents serve to objectively characterize the performance of equip-
ment and to facilitate the comparison of equipment of different vendors. They are not
primarily meant for recommendations with regard to QC parameters, procedures and
test frequencies but are nevertheless often used as such. In practice, many institutes
will select a subset of the NEMA tests to be used for QC, keeping in mind the afore-
mentioned aspects of costs and benefits.
It is interesting to identify as to why small-animal NEMA standards exist for PET
and not for SPECT. My personal feeling is that this might be attributed to the much
larger variety in parameters with regard to equipment hardware and acquisition and
reconstruction settings in small-animal SPECT as compared to PET. These include, for
instance, static versus rotating collimators, planar or cylindrical collimators, numbers
of pinholes, varying radii of rotation or collimator diameters, using separated or over-
lapping projections, etc. The variety of photon energy, as opposed to the fixed value of
511 keV in PET, requires different (pinhole) collimator designs. Moreover, attenuation
correction in single-photon detection is more of a challenge than in coincidence detection
of two collinear photons. All these items could have led to more difficult ‘consensus’ in
NEMA standards for small-animal SPECT than for small-animal PET.
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Guidelines
As stated above, NEMA tests have not primarily been set up as guidelines for acceptance
testing and QC. Specifically, the NEMA documents do not specify any recommended test
frequency, nor do they present an ‘order of importance’, based on the (pre)clinical
relevance of the parameters to be tested. For this purpose, we need guidelines. Several
guidelines for acceptance testing and QC of nuclear medicine equipment have already
been issued on behalf of the EANM Physics Committee. In both documents, guidelines
for small-animal PET are given, but small-animal SPECT is missing.
Table 11 in reference [65] summarizes the acceptance tests for small-animal PET and
their purpose and indicates whether a certain test is solely used for acceptance/
non-acceptance or whether it also generates reference values to be used in later
QC procedures. Several of the tests prescribe to straightforwardly follow the
NEMA NU4 procedures. These include sensitivity, count rate performance, image
quality, linearity and attenuation and scatter correction.
Table 9 in reference [66] summarizes the routine QC tests for small-animal PET, their
purpose and their recommended test frequency, which ranges from daily to yearly. In
terms of the cost-benefit trade-off, the daily tests (physical inspection, background count
rate, detector check) are of very short duration and do not require expensive tools of
phantoms. The weekly tests (energy resolution and pixel identification) at least require a
positron source. It will depend on the kind of system/vendor as to which source geometry
is described. For the Siemens Inveon, small-animal PET scanner, for example, the pixel
identification procedure is part of the ‘detector setup’ and requires a cylindrical phantom.
This procedure is somewhat time-consuming, and accordingly, the test frequency could
possibly be decreased, based on the procedure of ‘adaptive frequencies’ as described
above. The monthly, three monthly and yearly tests all require phantoms or sources and
can be relatively time consuming.
Absence of guidelines and NEMA standards for small-animal SPECT
NEMA standards and official guidelines for small-animal SPECT are still lacking, which
could be related to the considerations as described earlier. Several performance parame-
ters can be easily adapted from PET to SPECT. Parameters that are in common between
PET and SPECT are, for instance, image quality, spatial resolution, energy resolution and
sensitivity. However, some parameters are ‘PET-only’, such as coincidence timing, and
some of them are important for PET but to a much smaller extent for SPECT. These
include count rate performance and linearity (related to detector dead time). Since SPECT
scanners contain collimators, the rate of photons that reach the detector and photomulti-
pliers is generally much smaller than in PET, and therefore, dead-time and count rate
linearity is not an issue for activities normally administered to the animals in SPECT.
On the other hand, the large variety in single-photon emitters with different energies
and, accordingly, different collimators requires special attention in SPECT. In principle,
this requires that performance parameters be measured for each collimator (and even
for each radionuclide) separately. In view of a cost-benefit trade-off, one could however
decide to perform QC procedures with a high(er) test frequency for the mostly used
collimator and radionuclide and with a lower frequency for other combinations.
Furthermore, background radiation is expected to be much more of an issue in SPECT
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than in PET. Single photons not originating from the animal in the scanner are counted
in case the detector is not properly shielded in all directions, which is not the case for
coincidence photon detection in PET. Even for multi-pinhole collimators with a
large numbers of pinholes, the overall sensitivity in small-animal SPECT is lower
than in PET. This results in signal counts (from the animal) that could be close to
the background level. A pitfall is the presence of other animals, already injected
with a radiopharmaceutical, that are in present in the scanner room and not
properly shielded.
Fundamental or intrinsic parameters versus image parameters
It could be of importance to distinguish between parameters that can directly be seen
or measured in reconstructed images versus parameters that are more ‘fundamental’ to
the scanner. The latter type of parameters can also influence image quality, but the way
in which this happens is not always directly deducible.
Examples of ‘image parameters’ are spatial resolution as indicated by small structures
in the image (small spheres or rods used to calculate recovery coefficients), image
uniformity (signal-to-noise ratios, percentage standard deviation), spillover of activity
into cold regions and quantification (pixel values indicating Bq/cm3).
Parameters that can be identified as more fundamental are energy resolution including
photo peak position, coincidence timing performance, noise equivalent count rate,
intrinsic spatial resolution for gamma cameras, random correction performance in
PET and count rate linearity.
From a practical point of view, one could decide to only monitor image parameters
in a QC programme. From a cost-benefit point of view, this could be attractive, but
one runs the risk that some slow deterioration or deviations are already occurring
before they are visible in the image quality.
Preclinical phantoms
In any QC procedure, radioactive phantoms are needed that contain a certain distribution
of radioactive material such that specific performance properties of the scanner can be
monitored. These can be solid sources, generally point or line sources embedded in
attenuating material or phantoms containing hollow structures that can be filled with
radioactive solution, generally spheres, cylinders and background compartments.
In small-animal PET, for which NEMA performance parameters exist [5], the phantoms
to be used have been precisely defined. These are (i) a Na-22 point source embedded in
an acrylic cube of 10-mm sides for spatial resolution and sensitivity measurements, (ii)
line sources filled with a F-18 or C-11 solution, embedded in cylinders of polyethylene of
different sizes (simulating mice, rats and monkeys) to measure scatter fraction, count
losses and random coincidences, and (iii) an image quality phantom containing hollow
cylinders of 1–5-mm diameter filled with F-18 solution, two cylindrical compartments of
8-mm diameter filled with air and non-radioactive water and a background compartment
filled with F-18 solution. The image quality parameters to be determined using this
phantom are (i) recovery coefficients for the differently sized rods, indicative of spatial
resolution, (ii) spillover of activity into the cold air and water compartments, expressing
the scatter performance, and (iii) uniformity of measured activity in the background
compartment that indicates the signal-to-noise ratio.
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For small-animal SPECT, several of these phantoms and corresponding measurements
can be adapted from the ones used for PET, keeping in mind the already mentioned
fundamental differences in single-photon detection in SPECT versus coincidence detec-
tion in PET.
It should be mentioned furthermore that spatial resolution in SPECT cannot be mea-
sured in the same, straightforward manner as in PET. In both clinical and small-animal
PET, spatial resolution is measured using a point or line source, reconstructed with
filtered back projection (FBP). Since FBP is a vendor-independent, straightforward
reconstruction algorithm, results will be one-to-one comparable for systems of different
vendors. However, for multi-pinhole SPECT systems, image reconstruction is performed
using iterative algorithms that make use of the system response information including the
collimator and detectors. These iterative algorithms, however, do not provide unique
numbers for spatial resolution when reconstructing point or line sources. Instead, their
full-width-at-half-maximum (FWHM) in iteratively reconstructed images varies strongly
with the number of iterations (and subsets) being used. The general rule is that smaller
FWHM is obtained for larger numbers of iterations and subsets, at the cost of increase of
image noise. It is therefore recommended for small-animal SPECT to express spatial
resolution in terms of recovery coefficients for small spheres or rods in image quality
phantoms, instead of the FWHM of reconstructed point or line sources.
Finally, it should be mentioned that the activity present in any phantom used for
calibration or for QC should match the desired accuracy related to the maximum
allowable duration of the test. In general, when phantom activity has decayed to a
certain extent, the phantom can still be used by allowing for a longer scan duration.
One could for instance specify the minimum number of counts that should be acquired
instead of the duration of the scan. Special attention, however, should be paid to the
phantom activity not being comparable to the background activity in the laboratory. In
that case, one could still acquire ‘enough counts’, but these are then of little value since
image quality will be poor, and quantification will be inadequate.
Image quality phantoms
Several image quality phantoms are available for both small-animal PET and SPECT. The
phantom for NEMA small-animal PET was already mentioned. Furthermore, phantoms
exist containing small hollow spheres to be filled with radioactivity and inserted into a
non-zero background activity compartment (Microhollow sphere phantom) and
‘Derenzo-like’ phantoms containing hot rods in a cold background or cold rods in a radio-
active background (Mini Deluxe phantoms). Also, a downscaled version of the NEMA
NU4 PET phantom, accommodating the high spatial resolution of multi-pinhole small-
animal SPECT, has been proposed [67].
Discussion items
As indicated earlier, official guidelines for small-animal SPECT are still lacking,
whereas those for small-animal PET could be taken from reference (Busemann Sokole,
Płachcínska, & Britten, 2010; Busemann Sokole, Płachcínska, Britten, et al., 2010). In
implementing QC procedures in small-animal imaging, several decisions have to be
made. As a starting point, one could take the procedures in clinical practice as an
example and decide which procedures should be copied to the preclinical situation.
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Several important issues in the clinic, such as high radiation dose to patients and
wrong decisions in diagnosis or therapy, are less of an issue in preclinical research.
However, generating (and publishing) scientific results that are based on sub-optimal
imaging conditions or faulty processing is of course unwanted in both cases, especially
in view of the current discussions about integrity and quality of scientific data.
Cost-benefit discussions in preclinical imaging are expected to be similar to those
in clinical imaging. The necessity to repeat scans in case of equipment that is out
of order will directly lead to additional costs for radiopharmaceuticals and
personnel. In animal research, equipment that is non-usable for a too long time,
can even lead to the necessity to replace the animals, also leading to additional
costs and unwanted delay. As already mentioned, it is important to assess the bal-
ance between ‘image parameters’ and ‘fundamental parameters’ to be incorporated.
When only focusing on image parameters, costs will probably be lower, whereas
measuring all possible fundamental parameters will lead to early detection of any
possible system failure but will of course increase costs.
Finally, an interesting and important discussion issue is whether our goal is to
provide comprehensive guidelines for small-animal PET and SPECT imaging, or
whether it is worthwhile to move a step further, and work on an accreditation
programme of scanners and procedure along the lines of, for instance, the accreditation
for human FDG-PET as set up by EARL (see http://earl.eanm.org).
Conclusions
Reproducible animal experiments are very challenging due to the combination of the
different factors described above. To minimize the failure of often expensive studies, it
is important to attribute sufficient attention to each of the aspects described in this
paper. The following is a list of items to be considered when setting up a small-animal
imaging experiment:
1. Based on the main (biological) effect of interest, that needs to be investigated using
an imaging experiment, select the proper imaging modality. In preclinical nuclear
imaging, SPECT can provide sub-millimetre spatial resolution at sensitivities of
0.01–0.1 %, whereas PET can provide a spatial resolution of 1–2 mm but at
sensitivities mostly >1 %. SPECT might have an advantage when isotopes with
longer half-life are required when slower biological processes have to be
longitudinally monitored. Furthermore, SPECT can offer multi-isotope imaging.
2. Based on the main (biological) effect of interest, that needs to be investigated using
an imaging experiment, a correct animal model needs to be selected.
3. Select a proper control group of animals. Generally, these are healthy young
adult rodents.
4. Decide on an adequate sample size based on the expected differences that should
be observed between control and disease/treatment groups and the intra-animal
variability of the SPECT/PET measurements.
5. Related to animal handling, a general rule is to reduce any source of variability to
improve the precision of quantitative SPECT/PET measurements.
6. Thus, take attention to animal housing to avoid stress and monitor animal
health.
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7. If imaging requires fasting, the fasting period should be kept constant and at a
minimum, ideally less than 6 h. Drinking water should not be withdrawn, and
overnight fasting should be avoided.
8. During imaging experiments, animals are mostly immobilized by light anaesthesia.
It is very important to select a proper anaesthesia (and dosing) because some
anaesthetics may have influence on the biological effect of interest. This is especially
important when investigating the brain.
9. During anaesthesia, and thus mostly during SPECT/PET/CT acquisitions, animal
heating is required to maintain a constant body temperature.
10. When the tracer is administered to the animals, the volumes used for intravenous
injections should not exceed specific limits. The same applies for blood volumes
that have to be withdrawn in case of blood sampling.
11. After the imaging experiment, animals should be monitored during awakening
from anaesthesia.
12. For accurate quantification, the acquired SPECT/PET images should be
iteratively reconstructed and corrected for image degrading effects, such as
attenuation, scatter and partial volume effects. Moreover, a sufficient number
of iterations should be used and the reconstructed voxel size should be
sufficiently small (at least smaller than the system spatial resolution).
13. When sample counting (blood/tissue) is performed, cross-calibration between dose
calibrator, SPECT/PET camera and blood/gamma counter should be performed.
14. Finally, a quality control programme should be implemented to guarantee for
accurate and precise SPECT and PET quantifications.
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